Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

FDA

BioPhotonics
Sep 2007
The FDA has approved the CustomVue monovision lasik device from AMO/Visx Inc. of Santa Clara, Calif. The product is designed to fully correct nearsightedness in the patient’s dominant eye but only partially correct it in the nondominant one, allowing patients to view both nearby and distant objects after an adjustment period. In contrast to traditional lasik, the procedure may reduce the need for patients over the age of 40 to wear reading glasses.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!